Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 187

1.

The elusive diagnosis of sensory neuronopathy.

Willison HJ.

Arq Neuropsiquiatr. 2019 Jul 29;77(7):449-450. doi: 10.1590/0004-282X20190084. No abstract available.

2.

The Use of Myelinating Cultures as a Screen of Glycomolecules for CNS Repair.

McCanney GA, Lindsay SL, McGrath MA, Willison HJ, Moss C, Bavington C, Barnett SC.

Biology (Basel). 2019 Jun 28;8(3). pii: E52. doi: 10.3390/biology8030052.

3.

Current treatment practice of Guillain-Barré syndrome.

Verboon C, Doets AY, Galassi G, Davidson A, Waheed W, Péréon Y, Shahrizaila N, Kusunoki S, Lehmann HC, Harbo T, Monges S, Van den Bergh P, Willison HJ, Cornblath DR, Jacobs BC; IGOS Consortium.

Neurology. 2019 Jul 2;93(1):e59-e76. doi: 10.1212/WNL.0000000000007719. Epub 2019 Jun 7.

PMID:
31175208
4.

MyelinJ: An ImageJ macro for high throughput analysis of myelinating cultures.

Whitehead MJ, McCanney G, Willison HJ, Barnett SC.

Bioinformatics. 2019 May 16. pii: btz403. doi: 10.1093/bioinformatics/btz403. [Epub ahead of print]

PMID:
31095292
5.

Low sulfated heparins target multiple proteins for central nervous system repair.

McCanney GA, McGrath MA, Otto TD, Burchmore R, Yates EA, Bavington CD, Willison HJ, Turnbull JE, Barnett SC.

Glia. 2019 Apr;67(4):668-687. doi: 10.1002/glia.23562. Epub 2018 Dec 26.

6.

Glial Sulfatides and Neuronal Complex Gangliosides Are Functionally Interdependent in Maintaining Myelinating Axon Integrity.

McGonigal R, Barrie JA, Yao D, McLaughlin M, Cunningham ME, Rowan EG, Willison HJ.

J Neurosci. 2019 Jan 2;39(1):63-77. doi: 10.1523/JNEUROSCI.2095-18.2018. Epub 2018 Nov 16.

7.

Regional variation of Guillain-Barré syndrome.

Doets AY, Verboon C, van den Berg B, Harbo T, Cornblath DR, Willison HJ, Islam Z, Attarian S, Barroso FA, Bateman K, Benedetti L, van den Bergh P, Casasnovas C, Cavaletti G, Chavada G, Claeys KG, Dardiotis E, Davidson A, van Doorn PA, Feasby TE, Galassi G, Gorson KC, Hartung HP, Hsieh ST, Hughes RAC, Illa I, Islam B, Kusunoki S, Kuwabara S, Lehmann HC, Miller JAL, Mohammad QD, Monges S, Nobile Orazio E, Pardo J, Pereon Y, Rinaldi S, Querol L, Reddel SW, Reisin RC, Shahrizaila N, Sindrup SH, Waqar W, Jacobs BC; IGOS Consortium.

Brain. 2018 Oct 1;141(10):2866-2877. doi: 10.1093/brain/awy232.

8.

Differential binding patterns of anti-sulfatide antibodies to glial membranes.

Meehan GR, McGonigal R, Cunningham ME, Wang Y, Barrie JA, Halstead SK, Gourlay D, Yao D, Willison HJ.

J Neuroimmunol. 2018 Oct 15;323:28-35. doi: 10.1016/j.jneuroim.2018.07.004. Epub 2018 Jul 9.

9.

Anti-ganglioside Antibodies in Peripheral Nerve Pathology.

Willison HJ.

Methods Mol Biol. 2018;1804:173-188. doi: 10.1007/978-1-4939-8552-4_7. Review.

PMID:
29926408
10.

Gangliosides and Autoimmune Peripheral Nerve Diseases.

Goodfellow JA, Willison HJ.

Prog Mol Biol Transl Sci. 2018;156:355-382. doi: 10.1016/bs.pmbts.2017.12.010. Epub 2018 Mar 28. Review.

PMID:
29747820
11.

Autoimmune Neurological Conditions Associated With Zika Virus Infection.

Acosta-Ampudia Y, Monsalve DM, Castillo-Medina LF, Rodríguez Y, Pacheco Y, Halstead S, Willison HJ, Anaya JM, Ramírez-Santana C.

Front Mol Neurosci. 2018 Apr 11;11:116. doi: 10.3389/fnmol.2018.00116. eCollection 2018. Review.

12.

Zika virus infection in the returning traveller: what every neurologist should know.

Leonhard SE, Lant S, Jacobs BC, Wilder-Smith A, Ferreira MLB, Solomon T, Willison HJ.

Pract Neurol. 2018 Aug;18(4):271-277. doi: 10.1136/practneurol-2017-001789. Epub 2018 Apr 4. Review.

13.

Heparanase attenuates axon degeneration following sciatic nerve transection.

Whitehead MJ, McGonigal R, Willison HJ, Barnett SC.

Sci Rep. 2018 Mar 26;8(1):5219. doi: 10.1038/s41598-018-23070-6.

14.

Guillain-Barré syndrome in the 100 years since its description by Guillain, Barré and Strohl.

Hughes RAC, Cornblath DR, Willison HJ.

Brain. 2016 Nov 1;139(11):3041-3047. doi: 10.1093/brain/aww247. No abstract available.

PMID:
29106487
15.

Nodes, paranodes and neuropathies.

Fehmi J, Scherer SS, Willison HJ, Rinaldi S.

J Neurol Neurosurg Psychiatry. 2018 Jan;89(1):61-71. doi: 10.1136/jnnp-2016-315480. Epub 2017 Aug 17. Review.

PMID:
28819062
16.

Zika virus tropism and interactions in myelinating neural cell cultures: CNS cells and myelin are preferentially affected.

Cumberworth SL, Barrie JA, Cunningham ME, de Figueiredo DPG, Schultz V, Wilder-Smith AJ, Brennan B, Pena LJ, Freitas de Oliveira França R, Linington C, Barnett SC, Willison HJ, Kohl A, Edgar JM.

Acta Neuropathol Commun. 2017 Jun 23;5(1):50. doi: 10.1186/s40478-017-0450-8.

17.

International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome.

Jacobs BC, van den Berg B, Verboon C, Chavada G, Cornblath DR, Gorson KC, Harbo T, Hartung HP, Hughes RAC, Kusunoki S, van Doorn PA, Willison HJ; IGOS Consortium.

J Peripher Nerv Syst. 2017 Jun;22(2):68-76. doi: 10.1111/jns.12209.

PMID:
28406555
18.

Co-cultures with stem cell-derived human sensory neurons reveal regulators of peripheral myelination.

Clark AJ, Kaller MS, Galino J, Willison HJ, Rinaldi S, Bennett DLH.

Brain. 2017 Apr 1;140(4):898-913. doi: 10.1093/brain/awx012.

19.

Guillain-Barré syndrome: surveillance and cost of treatment strategies - Authors' reply.

Willison HJ, Jacobs BC, van Doorn PA.

Lancet. 2017 Jan 21;389(10066):253-254. doi: 10.1016/S0140-6736(17)30055-7. Epub 2017 Jan 20. No abstract available.

PMID:
28118915
20.

Guillain-Barré syndrome: a century of progress.

Goodfellow JA, Willison HJ.

Nat Rev Neurol. 2016 Dec;12(12):723-731. doi: 10.1038/nrneurol.2016.172. Epub 2016 Nov 18. Review.

PMID:
27857121
21.

Inhibition of complement in Guillain-Barré syndrome: the ICA-GBS study.

Davidson AI, Halstead SK, Goodfellow JA, Chavada G, Mallik A, Overell J, Lunn MP, McConnachie A, van Doorn P, Willison HJ.

J Peripher Nerv Syst. 2017 Mar;22(1):4-12. doi: 10.1111/jns.12194.

PMID:
27801990
22.

Microarray screening of Guillain-Barré syndrome sera for antibodies to glycolipid complexes.

Halstead SK, Kalna G, Islam MB, Jahan I, Mohammad QD, Jacobs BC, Endtz HP, Islam Z, Willison HJ.

Neurol Neuroimmunol Neuroinflamm. 2016 Sep 28;3(6):e284. eCollection 2016 Dec.

23.

Antiganglioside, antiganglioside-complex, and antiglycolipid-complex antibodies in immune-mediated neuropathies.

Goodfellow JA, Willison HJ.

Curr Opin Neurol. 2016 Oct;29(5):572-80. doi: 10.1097/WCO.0000000000000361. Review.

PMID:
27427992
24.

Anti-ganglioside antibodies are removed from circulation in mice by neuronal endocytosis.

Cunningham ME, McGonigal R, Meehan GR, Barrie JA, Yao D, Halstead SK, Willison HJ.

Brain. 2016 Jun;139(Pt 6):1657-65. doi: 10.1093/brain/aww056. Epub 2016 Mar 26.

25.

Guillain-Barré syndrome.

Willison HJ, Jacobs BC, van Doorn PA.

Lancet. 2016 Aug 13;388(10045):717-27. doi: 10.1016/S0140-6736(16)00339-1. Epub 2016 Mar 2. Review.

PMID:
26948435
26.

Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study.

Cao-Lormeau VM, Blake A, Mons S, Lastère S, Roche C, Vanhomwegen J, Dub T, Baudouin L, Teissier A, Larre P, Vial AL, Decam C, Choumet V, Halstead SK, Willison HJ, Musset L, Manuguerra JC, Despres P, Fournier E, Mallet HP, Musso D, Fontanet A, Neil J, Ghawché F.

Lancet. 2016 Apr 9;387(10027):1531-1539. doi: 10.1016/S0140-6736(16)00562-6. Epub 2016 Mar 2.

27.

C1q-targeted inhibition of the classical complement pathway prevents injury in a novel mouse model of acute motor axonal neuropathy.

McGonigal R, Cunningham ME, Yao D, Barrie JA, Sankaranarayanan S, Fewou SN, Furukawa K, Yednock TA, Willison HJ.

Acta Neuropathol Commun. 2016 Mar 2;4:23. doi: 10.1186/s40478-016-0291-x.

28.

Progress in inflammatory neuropathy -the legacy of Dr Jack Griffin.

Feldman EL, Hughes RA, Willison HJ.

Nat Rev Neurol. 2015 Nov;11(11):646-50. doi: 10.1038/nrneurol.2015.192. Epub 2015 Oct 13. Review.

PMID:
26458287
29.

The Diagnostic Utility of Determining Anti-GM1: GalC Complex Antibodies in Multifocal Motor Neuropathy: A Validation Study.

Galban-Horcajo F, Vlam L, Delmont E, Halstead SK, van den Berg L, van der Pol WL, Willison HJ.

J Neuromuscul Dis. 2015 Jun 4;2(2):157-165.

30.

Glycoconjugates and neuroimmunological diseases.

Willison HJ.

Adv Neurobiol. 2014;9:543-66. doi: 10.1007/978-1-4939-1154-7_25.

PMID:
25151396
31.

Commentary.

Chavada G, Willison HJ.

J Neurosci Rural Pract. 2014 Jan;5(1):65-7. No abstract available.

32.

The application of glycosphingolipid arrays to autoantibody detection in neuroimmunological disorders.

Galban-Horcajo F, Halstead SK, McGonigal R, Willison HJ.

Curr Opin Chem Biol. 2014 Feb;18:78-86. doi: 10.1016/j.cbpa.2014.01.008. Epub 2014 Feb 2. Review.

PMID:
24495749
33.

Neuronal expression of GalNAc transferase is sufficient to prevent the age-related neurodegenerative phenotype of complex ganglioside-deficient mice.

Yao D, McGonigal R, Barrie JA, Cappell J, Cunningham ME, Meehan GR, Fewou SN, Edgar JM, Rowan E, Ohmi Y, Furukawa K, Furukawa K, Brophy PJ, Willison HJ.

J Neurosci. 2014 Jan 15;34(3):880-91. doi: 10.1523/JNEUROSCI.3996-13.2014.

34.

Anti-GQ1b ganglioside positive Miller Fisher syndrome - evidence of paranodal pathology on nerve biopsy.

Miller JA, Spyropoulos A, Jaros E, Galban-Horcajo F, Whittaker RG, Willison HJ.

J Neuromuscul Dis. 2014;1(2):191-195.

PMID:
27858774
35.

Antibodies to heteromeric glycolipid complexes in Guillain-Barré syndrome.

Rinaldi S, Brennan KM, Kalna G, Walgaard C, van Doorn P, Jacobs BC, Yu RK, Mansson JE, Goodyear CS, Willison HJ.

PLoS One. 2013 Dec 16;8(12):e82337. doi: 10.1371/journal.pone.0082337. eCollection 2013.

36.

Antibodies to GM1: galactocerebroside complexes in multifocal motor neuropathy: it takes two to tango.

Willison HJ, Galban-Horcajo F, Halstead SK.

J Neurol Neurosurg Psychiatry. 2014 Jul;85(7):715. doi: 10.1136/jnnp-2013-306050. Epub 2013 Sep 4. No abstract available.

PMID:
24006050
37.

The pre-synaptic motor nerve terminal as a site for antibody-mediated neurotoxicity in autoimmune neuropathies and synaptopathies.

Fewou SN, Plomp JJ, Willison HJ.

J Anat. 2014 Jan;224(1):36-44. doi: 10.1111/joa.12088. Epub 2013 Aug 13. Review.

38.

Glycolipid antigens and autoantibodies in autoimmune neuropathies.

Willison HJ, Goodyear CS.

Trends Immunol. 2013 Sep;34(9):453-9. doi: 10.1016/j.it.2013.05.001. Epub 2013 Jun 13. Review.

PMID:
23770405
39.

Anti-GM2 ganglioside antibodies are a biomarker for acute canine polyradiculoneuritis.

Rupp A, Galban-Horcajo F, Bianchi E, Dondi M, Penderis J, Cappell J, Burgess K, Matiasek K, McGonigal R, Willison HJ.

J Peripher Nerv Syst. 2013 Mar;18(1):75-88. doi: 10.1111/jns5.12011.

40.

The effects of age and ganglioside composition on the rate of motor nerve terminal regeneration following antibody-mediated injury in mice.

Rupp A, Cunningham ME, Yao D, Furukawa K, Willison HJ.

Synapse. 2013 Jul;67(7):382-9. doi: 10.1002/syn.21648. Epub 2013 Mar 14.

41.

The translation of the pathological findings described in humans to experimental models of acute motor axonal neuropathy.

Willison HJ.

J Peripher Nerv Syst. 2012 Dec;17 Suppl 3:3-8. doi: 10.1111/j.1529-8027.2012.00423.x. Review.

PMID:
23279424
42.

Neurofascin antibodies in inflammatory neuropathy: how many needles make a haystack?

Hughes RA, Willison HJ.

Neurology. 2012 Dec 4;79(23):2224-5. doi: 10.1212/WNL.0b013e3182768b55. Epub 2012 Oct 24. No abstract available.

PMID:
23100403
43.

Guillain-Barré syndrome-related Campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies.

Islam Z, Gilbert M, Mohammad QD, Klaij K, Li J, van Rijs W, Tio-Gillen AP, Talukder KA, Willison HJ, van Belkum A, Endtz HP, Jacobs BC.

PLoS One. 2012;7(8):e43976. doi: 10.1371/journal.pone.0043976. Epub 2012 Aug 27.

44.

Autoantibodies in immune-mediated neuropathies.

Chavada G, Willison HJ.

Curr Opin Neurol. 2012 Oct;25(5):550-5. doi: 10.1097/WCO.0b013e328357a77f. Review.

PMID:
22941260
45.

Antibodies to MOG in NMO: a seasoned veteran finds a new role.

Willison HJ, Linington C.

Neurology. 2012 Sep 18;79(12):1198-9. doi: 10.1212/WNL.0b013e31826aadaf. Epub 2012 Aug 22. No abstract available.

PMID:
22914829
46.

Sialoadhesin promotes rapid proinflammatory and type I IFN responses to a sialylated pathogen, Campylobacter jejuni.

Klaas M, Oetke C, Lewis LE, Erwig LP, Heikema AP, Easton A, Willison HJ, Crocker PR.

J Immunol. 2012 Sep 1;189(5):2414-22. doi: 10.4049/jimmunol.1200776. Epub 2012 Jul 30.

47.

Antibodies to heteromeric glycolipid complexes in multifocal motor neuropathy.

Galban-Horcajo F, Fitzpatrick AM, Hutton AJ, Dunn SM, Kalna G, Brennan KM, Rinaldi S, Yu RK, Goodyear CS, Willison HJ.

Eur J Neurol. 2013 Jan;20(1):62-70. doi: 10.1111/j.1468-1331.2012.03767.x. Epub 2012 Jun 22.

48.

Sialylation of Campylobacter jejuni lipo-oligosaccharides: impact on phagocytosis and cytokine production in mice.

Huizinga R, Easton AS, Donachie AM, Guthrie J, van Rijs W, Heikema A, Boon L, Samsom JN, Jacobs BC, Willison HJ, Goodyear CS.

PLoS One. 2012;7(3):e34416. doi: 10.1371/journal.pone.0034416. Epub 2012 Mar 28.

49.

Anti-ganglioside antibody internalization attenuates motor nerve terminal injury in a mouse model of acute motor axonal neuropathy.

Fewou SN, Rupp A, Nickolay LE, Carrick K, Greenshields KN, Pediani J, Plomp JJ, Willison HJ.

J Clin Invest. 2012 Mar;122(3):1037-51. doi: 10.1172/JCI59110. Epub 2012 Feb 6.

50.

Motor nerve terminal destruction and regeneration following anti-ganglioside antibody and complement-mediated injury: an in and ex vivo imaging study in the mouse.

Rupp A, Morrison I, Barrie JA, Halstead SK, Townson KH, Greenshields KN, Willison HJ.

Exp Neurol. 2012 Feb;233(2):836-48. doi: 10.1016/j.expneurol.2011.12.010. Epub 2011 Dec 16.

PMID:
22197826

Supplemental Content

Loading ...
Support Center